Product Reports Resources Pricing Login Book a demo

Caribou Biosciences

Biotech & Life Sciences · Berkeley, United States · Founded 2011 · IPO 2021

Biotechnology company focused on genome engineering and developing technology-based solutions for cells

Valuation $54M
Revenue $26M
Power Law Unicorn$1–10B valuation tier Colt$25–100M revenue

Talent graph

Caribou Biosciences's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

29 investors on Caribou Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage
Genoa Ventures
David Beyer
Maverick Ventures
E-Merge
Novartis
Marc Bell Capital
Series B+ 23 investors entered at this stage
F-Prime
Janus Henderson Investors
Tekla Capital Management
Farallon Capital Management
Avego Bioscience Capital
LifeSci Venture Partners
Avidity Partners
Monashee Investment Management
Pontifax AgTech
Ridgeback Capital
AbbVie
Mission Bay Capital
Adage Capital
Heritage Medical Systems
The Leukemia & Lymphoma Society
Point72 Ventures
Maverick Capital
Anterra Capital
University of California
Berkeley
PFM Health Sciences
Invus
Heritage Group

Caribou Biosciences mafia

Startups founded by Caribou Biosciences alumni

Former Caribou Biosciences employees who went on to start their own companies. Sorted by Dealroom signal score.

Intellia TherapeuticsEst. 2014
AMAndy MayUnited States
Signal score86
Laguna BioEst. 2022
Jonathan KotulaUnited States
Signal score84
Locus BiosciencesEst. 2015
Rodolphe Barrangou.United States
Signal score76
Vetmab BiosciencesEst. 2022
Richard ChinUnited States
Signal score70
Editas MedicineEst. 2013
Jennifer A. DoudnaUnited States
Signal score62

Book a demo to explore the full alumni network →

Global footprint

Where Caribou Biosciences has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
8.8K monthly visits
across markets
🇺🇸 United States80.7%
🇮🇳 India11.4%
🇯🇵 Japan8%
Top 3 markets shown

Patent intelligence

$98M patent portfolio · 33 active families

Estimated portfolio value
$98M
182.0% of market cap · 24.3× smaller than top peer Illumina ($2.4B)
33 active patent families
Where Caribou Biosciences innovates BioinformaticsCAR - Chimeric antigen receptorCRISPRCell biologyExpression cassette

Where Caribou Biosciences concentrates vs peers

Each axis is a top-10 topic across Caribou Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Caribou Biosciences

An AI-synthesized read of the highest-engagement posts about Caribou Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Caribou Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles